A detailed history of Graney & King, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Graney & King, LLC holds 145 shares of LLY stock, worth $125,425. This represents 0.08% of its overall portfolio holdings.

Number of Shares
145
Holding current value
$125,425
% of portfolio
0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$727.2 - $932.06 $105,444 - $135,148
145 New
145 $112 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $822B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Graney & King, LLC Portfolio

Follow Graney & King, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graney & King, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graney & King, LLC with notifications on news.